Company / EPS (Diluted)
Collegium Pharmaceutical, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.73
FY2025
5-year range
-$0.74 / $1.86
FY2021-FY2025
Trend
-7.0%
vs FY2024
Sector context
#27 of 204
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s eps (diluted) of $1.73 is higher than 87% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-22.72 in FY2016 to $1.86 in FY2024.
Based on SEC 10-K filings.
1.73 in FY2025 with a 5-year CAGR of +17.9%. Top quartile in the Health Care sector.
Improved from $1.29 to $1.73 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
+232.8% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 7.0% year-over-year.
- Ranks #27 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.73 | -7.0% |
| FY2024 | $1.86 | +44.2% |
| FY2023 | $1.29 | +274.3% |
| FY2022 | -$0.74 | -139.8% |
| FY2021 | $1.86 | +144.7% |
| FY2020 | $0.76 | +130.8% |
| FY2019 | -$2.47 | -333.3% |
| FY2018 | -$0.57 | +61.5% |
| FY2017 | -$1.48 | +93.5% |
| FY2016 | -$22.72 | -3395.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026